These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2045345

  • 1. FDA fast-tracking of pet population control drugs.
    Weissinger J, McRae D.
    J Am Vet Med Assoc; 1991 Apr 01; 198(7):1231-3. PubMed ID: 2045345
    [Abstract] [Full Text] [Related]

  • 2. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE, Taylor DA.
    J Pharmacol Exp Ther; 2005 Sep 01; 314(3):939-44. PubMed ID: 15833895
    [Abstract] [Full Text] [Related]

  • 3. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan 01; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 4. Fort Dodge recalls ProHeart 6, citing FDA safety concerns. Advisory committee to review FDA findings.
    Kuehn BM.
    J Am Vet Med Assoc; 2004 Oct 15; 225(8):1157-8. PubMed ID: 15521431
    [No Abstract] [Full Text] [Related]

  • 5. [Diagnostic kits in parasitology: which controls?].
    Rossi P.
    Parassitologia; 2004 Jun 15; 46(1-2):145-9. PubMed ID: 15305705
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The investigative process for new drugs.
    Nicklas RA.
    Ann Allergy; 1989 Dec 15; 63(6 Pt 2):598-600. PubMed ID: 2688499
    [Abstract] [Full Text] [Related]

  • 8. Update: recall of dry dog and cat food products associated with human Salmonella Schwarzengrund infections--United States, 2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Nov 07; 57(44):1200-2. PubMed ID: 18987615
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drugs and other product choices.
    Hyman PM, Carvajal R.
    Dermatol Ther; 2009 Nov 07; 22(3):216-24. PubMed ID: 19453345
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy termination in the bitch and queen.
    Eilts BE.
    Clin Tech Small Anim Pract; 2002 Aug 07; 17(3):116-23. PubMed ID: 12476814
    [Abstract] [Full Text] [Related]

  • 12. Food and Drug Administration monitoring of adverse drug reactions.
    Sills JM, Tanner LA, Milstien JB.
    Am J Hosp Pharm; 1986 Nov 07; 43(11):2764-70. PubMed ID: 3799612
    [Abstract] [Full Text] [Related]

  • 13. Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulator.
    Borer JS.
    J Am Coll Cardiol; 2004 Dec 21; 44(12):2285-92. PubMed ID: 15607388
    [Abstract] [Full Text] [Related]

  • 14. New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule.
    Fed Regist; 1992 Dec 11; 57(239):58942-60. PubMed ID: 10123232
    [Abstract] [Full Text] [Related]

  • 15. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ.
    Pharmacotherapy; 2008 Aug 11; 28(8):992-8. PubMed ID: 18657016
    [Abstract] [Full Text] [Related]

  • 16. The role of the FDA in the effort against AIDS.
    Young FE.
    Public Health Rep; 1988 Aug 11; 103(3):242-5. PubMed ID: 3131814
    [Abstract] [Full Text] [Related]

  • 17. Food and Drug Administration approves vaginal sponge.
    Kafka D, Gold RB.
    Fam Plann Perspect; 1983 Aug 11; 15(3):146-8. PubMed ID: 6347710
    [Abstract] [Full Text] [Related]

  • 18. When is a cost-effectiveness claim valid? How much should the FDA care?
    Luce BR, Hillman AL.
    Am J Manag Care; 1997 Nov 11; 3(11):1660-6. PubMed ID: 10178464
    [Abstract] [Full Text] [Related]

  • 19. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G.
    Eur J Clin Pharmacol; 2002 Nov 11; 58(8):495-500. PubMed ID: 12451425
    [Abstract] [Full Text] [Related]

  • 20. Selected Proceedings of the NICHD/FDA newborn drug development initiative: Part II.
    Giacoia GP, Mattison DR.
    Clin Ther; 2006 Sep 11; 28(9):1337-41. PubMed ID: 17062307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.